News

Research News – Monday, August 26, 2024

Published: Monday, August 26, 2024

SCROLL TO END FOR DOCUMENTS TO DOWNLOAD

REMINDERS

Interested in becoming an IRB Member?

The OUHSC Institutional Review Board (IRB) currently has openings for new IRB members. The IRB reviews applications and reports for human research projects to ensure that the rights and welfare of human participants are protected and that risk of harm is minimized.

If you are interested in medical or social science research and would like to be involved with protecting the rights, safety and welfare of individuals who volunteer to participate in research, IRB membership may be for you. Current members have expressed that of all the committee’s they have participated in, the IRB has been the most rewarding. Members enjoy an increased understanding of research and exposure to cutting edge issues and current controversies in medical diagnostics and treatments. In addition, valuable collaboration may result from working closely with board members from a variety of disciplines.

If you are interested in learning more about IRB membership, please contact the HRPP Office at 405-271-2045 or email to donna-hogan@ouhsc.edu

ORA Reminder: HSCORA@ouhsc.edu is the primary central inbox for sending general inquiries to ORA. When sending an email request, please include the PI name and SoonerTrack request form number as applicable. ORANOA@ouhsc.edu is our primary award inbox and is used on grant applications to centralize emails from sponsors in regard to submitted applications and notices of awards. ORADMIN@ouhsc.edu should only be used to request items be included in our weekly ORA newsletter. No other central email addresses are used for communication with ORA.

NIH Policy Reminder

NIH awards are made to recipients, which are most often institutions, not individuals. NIH grants-policy staff members conduct official business with the Authorized Organization Representative (AORs), as detailed in NIHGPS Chapter 2.1.2 Recipient Staff. As a reminder, inquiries regarding general grants-policy matters are best directed first to the recipient’s Office of Sponsored Programs; specifically, the AOR. In rare instances where these contacts are not able to assist in resolving the inquiry, or determine a need to seek guidance from the NIH on a complex or unusual policy circumstance, recipient/applicant’s AOR, not the PD/PI, may submit policy-related inquiries on the organization’s behalf to the NIH grants policy inbox.

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-151.html

WORKSHOPS AND SEMINARS

The 2024 Oklahoma Conference for statistical innovation and application in the era of data science is coming to the OU Hudson College of Public Health on Monday, October 14 and Tuesday, October 15. Registration is now open and includes lunch, snacks, beverages, live presentations, interaction and social networking with speakers, and a copy of the recorded presentations each day! Virtual and in-person session options are available. Special rates for students!

Visit https://obsc.ouhsc.edu/ to see the agenda, details and accommodations. Register here by October 9, 2024

CALLING ALL STUDENTS: The Oklahoma Conference for Statistics, Biostatistics, and Data Science invites students to submit a poster for presentation during the conference on Tuesday, October 15. Two winners will receive a $200 award. Submit your posters to sixia-chen@ouhsc.edu by October 7, 2024.

Please join the Institutional Research Core Facility for a Lunch and Learn with Parse Biosciences. Paige Gear will be covering their Single Cell Evercode technology, and Dr. Pepe Alberola-lla, with OMRF, will be presenting data produced from this Single Cell approach.

When: Monday, August 26^th

Time: 12:00 – 1:00pm

Where: Nicholson Tower, Room A

1000 NE 13^th St., Suite 1C

Oklahoma City, OK 73104

Please register at: https://resources.parsebiosciences.com/seminar-oklahoma

Harold Hamm Diabetes Center (HHDC) Research Symposium Call for Abstracts - The deadline for Abstract submission for the HHDC 2024 Research Symposium is Friday, September 20, 2024. Abstracts must be received by 5 p.m. HHDC 2024 Research Symposium will be held on Friday, November 15, 2024, at the Samis Education Center in Children’s Hospital in Oklahoma City. The Symposium will consist of selected oral presentations, and a keynote address by Matthew J. Potthoff, PhD, University of Iowa Carver College of Medicine, and a presentation by Sue Bodine, PhD, Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences. All abstracts submitted by trainees will be presented as short 5-slide talks at concurrent sessions, and will be recognized with awards, based on panel judges’ review. Eligibility for awards will be restricted to presentations where a trainee (MD fellows, resident, student) or junior faculty member (instructor, assistant professor, post-doc) is the first author and presenting their work. Four abstracts from Junior faculty submissions will be selected for 10-minute talks during the morning sessions, but are not award eligible. In addition to oral presentations, all abstracts may also be presented at the poster reception at the end of the day. For abstract submission guidelines and to RSVP for this free event, please go to: https://www.ouhealth.com/harold-hamm-diabetes-center/diabetes-research/diabetes-lectures-seminars-visiting-professorshi/diabetes-research-symposium/#~5fbdaf19-7927-44c8-a9ae-80c4f70f8755

For questions about eligibility, contact Ann-Olson@ouhsc.edu. For any other questions about this event, please contact lark-zink@ouhsc.edu.

FUNDING OPPORTUNITIES

Oklahoma Nathan Shock Center: Pilot Award Opportunity

Description: The Oklahoma Nathan Shock Center is soliciting applications to support the research of early-stage investigators, and senior investigators initiating new research programs in aging/geroscience, that can serve as the base for the development of new applications for NIA funding. The projects should utilize services provided by the Oklahoma Nathan Shock Center Cores as described on the NSC website (oklahomanathanshockcenteronaging.org). The awards range from $5,000 to $20,000 depending on the specific needs of the applicant. Applications from outside the University of Oklahoma Health Sciences, the Oklahoma Medical Research Foundation, and the Oklahoma City VA Health Care system, as well as collaborative projects with other Nathan Shock Centers are strongly encouraged.

Deadline for Submission: October 18, 2024

Link to the Full Announcement: Please see attached (Oklahoma Nathan Shock Pilot 2024)

Presbyterian Health Foundation (PHF) Clinician Scientist Development Grant Program – Request for Applications

Cycle I PHF Clinician Scientist Development Grant Program Deadline: October 2, 2024

The primary objective of the PHF Clinician Scientist Development Grant Program is to provide funding to a new or early-stage clinician scientist faculty member. This award is designed to support the applicant’s clinical and/or translational research project and to assist him or her with advancing this research project to a level that will be competitive for funding through a federal career development award mechanism. This program can provide funding for up to two years. The second year of funding will be based on successful achievement of identified milestones, completion of an application for Year Two funds, and whether funds are available.

The Principal Investigator must be an OUHSC primary faculty member with appointment at OUHSC as an Assistant Professor. New or early-stage clinical scientist faculty members with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC. Requests should be sent to ORA4PHF@ouhsc.edu). Applicants must not have had a prior NIH career development award or an independent NIH R01 award; must have an independent clinical and/or translational research project; must have an identified senior, experienced research mentor; and may not have another PHF grant during the duration of this award.

2025 OK-INBRE Research Project Investigator Awards – Request for Proposals

Deadline: October 31, 2024

The Oklahoma IDeA Network for Biomedical Research Excellence (OK-INBRE) is soliciting applications for its Research Project Investigator (RPI) award program. The purpose of the RPI program is to foster and develop biomedical research programs designed to generate preliminary data that enhances the competitiveness of the investigator for future extramural funding. Full-time, tenure track faculty members (or equivalent) at the University of Oklahoma Health Sciences or the Oklahoma Medical Research Foundation who qualify as an Early-Stage Investigator as defined by the NIH are eligible to apply. Awarded projects will receive up to $100,000 in direct costs per year plus applicable F&A costs for up of two years. The forms, instructions, and submission information can be found on the OK-INBRE website. Questions regarding this OK-INBRE funding opportunity can be directed to okinbre@ouhsc.edu or Dr. Mark Lang at mark-lang@ouhsc.edu.

The Searle Scholars Program makes grants to selected universities and research institutes to support the independent research of exceptional young faculty in the biomedical sciences and chemistry. Applicants for the 2025 competition are expected to be pursuing independent research careers in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine, and the biological sciences. The 2025 award will be in the amount of $300,000 ($100,000 per year for three years). OUHSC can submit one application in response to this announcement. Eligible faculty are invited to submit an internal pre-proposal via email to HSCORA@ouhsc.edu by 5 pm on August 23, 2024. Details can be found at https://searlescholars.org/ and in the attached announcement.

Presbyterian Health Foundation (PHF) Technology Advancement Grant (TAG) Program – Request For Applications

Cycles I-III PHF TAG Grant Program Deadline: ROLLING APPLICATIONS

The TAG program replaces the Equipment grant program. The primary objective of the PHF TAG program is to provide partial funding for critically needed research equipment that could be transformative for the research mission at OUHSC. This program is fully aligned with Pillar 1 of the Strategic Plan. The TAG program will proactively and with the help of a committee address campus-wide needs and fill critical gaps, with the goals to grow the research enterprise, expand innovative technology and research infrastructure, and promote addition of new cutting-edge technology on campus. Funding priority will be given to research equipment that will permit OUHSC investigators to be more competitive for external funding and provides support to multiple users. Funds may be used for equipment to be purchased as part of a recruitment package for new faculty or for equipment to support the research of current faculty. If the funds will be used for a new recruit, the recruit must have signed the offer letter with a specific start date or specific start date time frame. Equipment and/or technology funded by PHF is expected to be made available to all researchers at OUHSC, whenever possible. All OUHSC Assistant, Associate, or Full Professors are eligible to apply. Applicants are required to match requested funds. The maximum allowable budget for this program is $500,000 (PHF funding: $250,000; Applicant funding: $250,000). The minimum allowable budget for this program is $60,000 (PHF funding: $30,000; Applicant funding: $30,000). Only one application will be accepted per investigator per year. ATTACHMENT

NIH NOTICES

AHRQ Grantees - Upcoming Mandatory Submission of Final Reports in eRAs Grant Closeout (GC) Module for AHRQ Awards that end after October 1, 2024 (NOT-HS-24-020)

Notice of Information: Updates to the Data Repository for the Adolescent Brain Cognitive Development (ABCD) Study and the HEALthy Brain and Child Development (HBCD) Study (NOT-DA-24-038)

Retirement of NIHs Automated Just-in-Time Email Notification (NOT-OD-24-165)

Notice of the Reopening of the Public Comment Period for NOT-OD-24-144 "Notice of Availability: National Institutes of Health Draft Public Access Policy" (NOT-OD-24-166)

Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
(NOT-TW-24-009)

Request for Information (RFI): Inviting Comments on Early Career Stage Training Programs to Support Capacity Building for Music and Health Research

(NOT-AT-24-052)

Request for Information (RFI): Expanding the Technology Focus of the National and Regional Resources (NRRs) and Biomedical Technology Optimization and Dissemination (BTOD) Programs (NOT-GM-24-045)

Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in PAR-23-166, Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) (NOT-AI-24-073)

Notice of Change to Extend Last Receipt Date and the Expiration Date for PAR-21-187 and PAR- 21-188 (NOT-DC-24-040)

Notice of NIDDK Participation in RFA-MD-24-003 "Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)" (NOT-DK-24-030)

Notice of Intent to Publish a Funding Opportunity Announcement for NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) (NOT-AG-24-060)

Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)

(NOT-CA-24-096)

Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)

(NOT-CA-24-097)

Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional) (NOT-NR-24-011)

Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) (NOT-NS-24-130)

Notice of Special Interest (NOSI): Research on Illicit Drug Markets (NOT-DA-26-008)

Notice of Special Interest (NOSI): Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01-Clinical Trial Not Allowed) (NOT-DK-24-029)

NOTE: When only one application is allowed per Institution according to the sponsor instructions, please send a copy of the guidelines to HSCORA@ouhsc.edu as soon as the PI or department is aware of limited eligibility. ORA will review and provide further instructions regarding next steps in the process.